|
|
|
|
| LEADER |
01118naa a2200289 i 4500 |
| 001 |
NSK01001027300 |
| 003 |
HR-ZaNSK |
| 005 |
20220127150645.0 |
| 007 |
ta |
| 008 |
190412s2017 ci | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)001027300
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 100 |
1 |
|
|a Găvan, Alexandru
|4 aut
|
| 245 |
1 |
0 |
|a Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach /
|c Alexandru Găvan, Alina Porfire, Cristina Marina, Ioan Tomuţă.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 34 jed.
|
| 653 |
|
0 |
|a Kvetiapin
|a Antipsihotički lijekovi
|a Hidrofilne tvari
|a Oslobađanje lijeka
|a Produljeno oslobađanje lijeka
|a Planiranje pokusa
|
| 700 |
1 |
|
|a Porfire, Alina
|4 aut
|
| 700 |
1 |
|
|a Marina, Cristina
|4 aut
|
| 700 |
1 |
|
|a Tomuṯã, Ioan
|4 aut
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 67 (2017), 1 ; str. 53-70
|w nsk.(HR-ZaNSK)000054908
|
| 981 |
|
|
|b B04/17
|
| 998 |
|
|
|b milo1904
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/172765
|y Elektronička verzija članka
|